| |
| |
|
| Insider
Information: |
Humphries William D. |
| Relationship: |
Director |
| City: |
Alpharetta |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
427,069 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,920,207 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
427,069 |
|
|
| Total
Value |
$1,920,207 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
4
|
|
Stock
price went up :
|
1
|
4
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
 -15.7%
|
 175.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bausch Health Companies Inc |
BHC |
President, Ortho-Derma... |
2020-12-04 |
235,035 |
2017-01-02 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
2024-06-01 |
28,732 |
2020-03-02 |
0 |
Premium* |
|
|
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-09-22 |
51,040 |
2020-08-18 |
0 |
Premium* |
|
|
Strata Skin Sciences Inc |
SSKN |
|
2023-07-05 |
109,724 |
2021-07-20 |
0 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
2,538 |
2023-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BHC |
Bausch Health Companies I... |
President, Ortho-Dermatologics |
• • – |
2020-12-04 |
4 |
S |
$19.87 |
$2,266,398 |
D/D |
(114,055) |
235,035 |
0 |
% |
|
| BHC |
Bausch Health Companies I... |
President, Ortho-Dermatologics |
• • – |
2020-12-04 |
4 |
OE |
$14.38 |
$1,640,111 |
D/D |
114,055 |
349,090 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2020-08-18 |
4 |
B |
$1.78 |
$9,943 |
D/D |
5,586 |
5,586 |
2.39 |
% |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2022-01-10 |
4 |
OE |
$0.15 |
$3,409 |
D/D |
22,727 |
28,313 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2023-09-22 |
4 |
OE |
$0.40 |
$9,091 |
D/D |
22,727 |
51,040 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2023-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,538 |
2,538 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
|
• • – |
2021-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
41,583 |
41,583 |
0 |
- |
|
| SSKN |
Strata Skin Sciences Inc |
|
• • – |
2022-03-24 |
4 |
B |
$1.58 |
$23,387 |
D/D |
14,783 |
467,490 |
0.01 |
% |
|
| SSKN |
Strata Skin Sciences Inc |
|
• • – |
2022-03-25 |
4 |
B |
$1.73 |
$29,385 |
D/D |
16,950 |
484,440 |
0.01 |
% |
|
| SSKN |
Strata Skin Sciences Inc |
|
• • – |
2023-07-05 |
4 |
A |
$1.03 |
$37,500 |
D/D |
36,408 |
109,724 |
0 |
- |
|
35 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
